Bob Gadwood attended Marquette University from 1970-1974. He graduated summa cum laude with a BS in chemistry. Bob did his graduate work at the University of Wisconsin with Professor Edwin Vedejs where he worked on the synthesis of cytochalasin D. While at Wisconsin, Bob received an NSF predoctoral fellowship and a WARF fellowship. He received his Ph.D. in 1978. From Wisconsin, Bob traveled to University of Pittsburgh, where he was an NIH postdoctoral fellow. Bob did postdoctoral research on the total synthesis of quadrone for Professor Sam Danishefsky from 1978-1979. He did a second postdoctoral project with Professor Jules Rebek on the synthesis of novel crown ethers from 1979-1980.
In 1980, Bob took a position as Assistant Professor at Northwestern University. While at Northwestern, Bob worked on the total synthesis of cyclooctane-containing natural products and achieved the first total synthesis of poitediol.
In 1986, Bob left Northwestern to take a position as Senior Scientist at the Upjohn Company in Kalamazoo, Michigan. Over the next 17 years, Upjohn underwent a series of mergers to become Pharmacia and Upjohn, and then Pharmacia. In 2003, Pharmacia was acquired by Pfizer. At the time of the acquisition, Bob was an Associate Director of Medicinal Chemistry. While at Upjohn, Bob worked in a variety of areas including hair growth and antibacterials.
In 2003, Bob left Pfizer to start a new company called Kalexsyn (www.kalexsyn.com). This company is a contract medicinal chemistry company located in Kalamazoo, Michigan. Kalexsyn provides chemistry resources to pharmaceutical and biotech companies.
Bob is married (to a Marquette alumna that he met at Marquette) and has two children.